Garcia C., Lejon Veerle, Horna G., Astocondor L., Vanhoof R., Bertrand S., Jacobs J.
Source
Journal of Clinical Microbiology, 2014,
52 (3), p. 968-970 ISSN 0095-1137
Thirty-three Salmonella enterica serovar Typhi blood isolates from Lima, Peru (2008 to 2012), were fully susceptible to trimethoprim-sulfamethoxazole, chloramphenicol, ceftriaxone, and tetracycline; 8/33 (24.2%) showed intermediate susceptibility to ciprofloxacin carrying mutations in the quinolone resistance-determining region of the gyrA gene (Ser83-Phe and Asp87-Asn) and in the gyrB gene (Ser464-Phe).
